110
Participants
Start Date
May 10, 2017
Primary Completion Date
June 24, 2022
Study Completion Date
December 31, 2025
RelayPro
Endovascular treatment with investigational device.
Lankenau Medical Center, Wynnewood
University of Pennsylvania Medical Center / Penn Presbyterian, Philadelphia
Emory University, Atlanta
University of Florida, Gainesville
University of Alabama-Birmingham, Birmingham
Centennial Heart & Vascular Institute Sarah Cannon Research Institute, Nashville
Vanderbilt University Medical Center, Nashville
University Hospitals, Cleveland
Cleveland Clinic Foundation, Cleveland
Indiana University Health, Indianapolis
St. Vincent Heart Center, Indianapolis
University of Michigan, Ann Arbor
University of Iowa Hospital and Clinic, Iowa City
Baylor Scott & White Medical Center - Plano The Heart Hospital, Plano
University of Texas Southwestern, Dallas
Baylor Scot & White Medical Center - Temple, Temple
Arizona Heart Institute, Phoenix
Long Beach Memorial Hospital, Long Beach
University of California, Irvine, Irvine
Hartford Hospital, Hartford
Tufts Medical Center, Boston
Beth Israel Deaconess Medical Center / Harvard Medical School, Boston
Baystate Medical Center, Springfield
Newark Beth Israel Medical Center, Newark
Nagoya University Hospital, Nagoya
Hiroshima University Hospital, Hiroshima
Teine Keihinkai Hospital, Sapporo
Nara Medical University Hospital, Kashihara
Niigata University Medical & Dental Hospital, Niigata
Oita University Hospital, Yufu
Morinomiya Hospital, Joto-ku
National Cerebral & Cardiovascular Center, Suita
Jichi Medical University Saitama Medical Center, Ōmiya
Jikei University Hospital, Minato-Ku
Keio University Hospital, Shinjuku-Ku
Lead Sponsor
Bolton Medical
INDUSTRY